Rheumatic fever recurrence: a possible cause of restenosis after percutaneous mitral valvuloplasty

A Nigri1, N Alessandri, E Martuscelli

  • 1Institute of Cardiac Surgery, La Sapienza University of Rome, Italy. antonio.nigri@uniroma1.it

Abstract

Insights

A rapid restenosis process after percutaneous mitral valvuloplasty (PMV) can occur due to recurrent acute rheumatic fever. Prophylactic treatment may be considered for high-risk patients to prevent this complication.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Rheumatic Heart Disease

Background:

  • Percutaneous mitral valvuloplasty (PMV) is a procedure to treat mitral stenosis.
  • Restenosis, the re-narrowing of the mitral valve, is a known complication after PMV.
  • Acute rheumatic fever recurrence can trigger rapid restenosis.

Purpose of the Study:

  • To evaluate the occurrence of rapid restenosis after PMV.
  • To investigate the role of recurrent acute rheumatic fever in PMV restenosis.
  • To identify potential mechanisms and preventive strategies for restenosis after PMV.

Main Methods:

  • A retrospective study of 120 patients who underwent transseptal PMV from 1986 to 1996.
  • Mean follow-up duration of 58 months.
  • Analysis of restenosis occurrence and its timing relative to acute rheumatic fever recurrence.

Main Results:

  • Restenosis occurred in 8.3% of patients (10 out of 120).
  • Four patients experienced rapid restenosis within 1-3 months post-PMV, associated with rheumatic fever recurrence.
  • Six patients showed a gradual loss of mitral valve area gain over time.

Conclusions:

  • Two mechanisms of restenosis after PMV are suggested: a slow process from turbulent flow-trauma and a rapid process linked to rheumatic fever recurrence.
  • Prophylactic treatment might be beneficial for high-risk patients susceptible to streptococcal infections to prevent rapid restenosis.
  • Further research into prophylactic strategies is warranted, especially for patients with a history of rheumatic fever.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...